Sun, Apr 20, 2014, 12:16 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • one_dogydog one_dogydog Jan 20, 2013 10:31 AM Flag

    ARNA is managing its costs better as the R&D costs decreased by over $3 million from the comparable period.

    The company had a strong third quarter in 2012, which is likely contributing to some of the momentum seen in the chart above. Arena recorded $25.7 million in revenues compared to the same period in 2011, which only generated $10.6 million. Additionally, the company appears to be managing its costs better as the R&D costs decreased by over $3 million from the comparable period. With strong catalysts, institutional buying, and technical momentum, the stock may have a strong year.

    Sentiment: Strong Buy

 
ARNA
6.18-0.12(-1.90%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST